Search research articles
Contact Us
Filters
Showing results (31-40 of 192) with videos related to
Page
of 20
Sort By:
The Oncologist
|
July 24, 2019
Meta-Analysis of Randomized Clinical Trials Comparing Active Treatment with Placebo in Metastatic Neuroendocrine Tumors
Jaume Capdevila, Jorge Hernando, Santiago Perez-Hoyos, et al.
Clinical Colorectal Cancer
|
September 17, 2008
Update on novel strategies to optimize cetuximab therapy in patients with metastatic colorectal cancer
Teresa Macarulla, Francisco Javier Ramos, Elena Elez, et al.
Expert Review of Anticancer Therapy
|
August 14, 2008
Oxaliplatin-based chemotherapy in the management of colorectal cancer
Jaume Capdevila, Elena Elez, Sergio Peralta, et al.
Expert Review of Anticancer Therapy
|
July 14, 2007
New approaches in systemic treatment of advanced colorectal cancer: the molecular targets era
Jaume Capdevila, Guillermo Mendez, Teresa Macarulla, et al.
Oncology Letters
|
August 22, 2018
Concurrent palliative external radiotherapy with sorafenib or doxorubicin for bulky differentiated thyroid carcinoma: A case report
Karen S Cortés-Mateus, Katarzyna Holub, Fabricio Racca, et al.
BMC Cancer
|
November 9, 2016
Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program
Isabel Sevilla, Ángel Segura, Jaume Capdevila, et al.
Cancer Metastasis Reviews
|
April 17, 2013
The targeted therapy revolution in neuroendocrine tumors: in search of biomarkers for patient selection and response evaluation
Sara De Dosso, Enrique Grande, Jorge Barriuso, et al.
Journal of the American Academy of Dermatology
|
August 16, 2006
Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients
Esther Roé, María Pilar García Muret, Eugenio Marcuello, et al.
Cancer Treatment Reviews
|
March 10, 2009
Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment
Jaume Capdevila, Elena Elez, Teresa Macarulla, et al.
Frontiers in Oncology
|
May 19, 2023
Current perspectives on the management of patients with advanced <i>RET</i>-driven thyroid cancer in Europe
Rossella Elisei, Enrique Grande, Michael C Kreissl, et al.
Page
of 20
Search research articles
Search
Showing results (31-40 of 192) with videos related to
Sort By:
Page
of 20
The Oncologist
|
July 24, 2019
Meta-Analysis of Randomized Clinical Trials Comparing Active Treatment with Placebo in Metastatic Neuroendocrine Tumors
Jaume Capdevila, Jorge Hernando, Santiago Perez-Hoyos, et al.
Clinical Colorectal Cancer
|
September 17, 2008
Update on novel strategies to optimize cetuximab therapy in patients with metastatic colorectal cancer
Teresa Macarulla, Francisco Javier Ramos, Elena Elez, et al.
Expert Review of Anticancer Therapy
|
August 14, 2008
Oxaliplatin-based chemotherapy in the management of colorectal cancer
Jaume Capdevila, Elena Elez, Sergio Peralta, et al.
Expert Review of Anticancer Therapy
|
July 14, 2007
New approaches in systemic treatment of advanced colorectal cancer: the molecular targets era
Jaume Capdevila, Guillermo Mendez, Teresa Macarulla, et al.
Oncology Letters
|
August 22, 2018
Concurrent palliative external radiotherapy with sorafenib or doxorubicin for bulky differentiated thyroid carcinoma: A case report
Karen S Cortés-Mateus, Katarzyna Holub, Fabricio Racca, et al.
BMC Cancer
|
November 9, 2016
Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program
Isabel Sevilla, Ángel Segura, Jaume Capdevila, et al.
Cancer Metastasis Reviews
|
April 17, 2013
The targeted therapy revolution in neuroendocrine tumors: in search of biomarkers for patient selection and response evaluation
Sara De Dosso, Enrique Grande, Jorge Barriuso, et al.
Journal of the American Academy of Dermatology
|
August 16, 2006
Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients
Esther Roé, María Pilar García Muret, Eugenio Marcuello, et al.
Cancer Treatment Reviews
|
March 10, 2009
Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment
Jaume Capdevila, Elena Elez, Teresa Macarulla, et al.
Frontiers in Oncology
|
May 19, 2023
Current perspectives on the management of patients with advanced <i>RET</i>-driven thyroid cancer in Europe
Rossella Elisei, Enrique Grande, Michael C Kreissl, et al.
Page
of 20